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ABSTRACT 
 
The modern diet doesn’t provide the required amount of beneficial bacteria. Maintenance of a proper microbial 
ecology in the host is the main criteria to be met for a healthy growth. Probiotics are one such alternative that are 
supplemented to the host where by and large species of Lactobacillus, Bifidobacterium and Saccharomyces are 
considered as main probiotics. The field of probiotics has made stupendous strides though there is no major break 
through in the identification of their mechanism of action. They exert their activity primarily by strengthening the 
intestinal barrier and immunomodulation. The main objective of the study was to provide a deep insight into the 
effect of probiotics against the diseases, their applications and proposed mechanism of action. 
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INTRODUCTION 
 
The gut microenvironment has an effect on the 
nutrition, feed conversion and disease of the host, 
thereby maintaining the microbial ecology of the 
gut (Guarner and Malagelada 2003). During the 
periods of stress, illness or antibiotic treatment, the 
gut flora is often changed in favor of harmful 
bacteria that may cause diarrhea and loss of 
appetite (Cremonini et al. 2002; Harish and 
Varghese 2006). Overgrowth of the harmful 
bacteria and its subsequent invasion of the system 
lead to inflammatory, immunological, neurological 
and endocrinological problems. Induction of the 
growth of beneficial bacteria is one of the possible 
solutions to normalize the health conditions. This 
could be achieved by the supplementation of 
viable bacterial cells into the host. Probiotics can 
help to build up the beneficial bacterial flora in the 
intestine and completely exclude the pathogenic 
bacteria. These bacteria also release some enzymes 
which help in the digestion of the feed (Jean et al. 
2003). A daily intake of 109-1010 colony forming 
units (CFU) viable cells has been shown to have 
positive effect on the host health.  
There are many microorganisms that could 
potentially function as probiotic, of which 
Lactobacillus and Bifidobacterium species are the 
most commonly used. Probiotics are live 
microorganisms thought to be beneficial to the 
host organism. According to the currently adopted 
definition by FAO/WHO, probiotics are live 
microorganisms, which when administered in 
adequate amounts confer a health benefit on the 
host. In addition, nonpathogenic species belonging 
to the class of Saccharomyces, Streptococcus and 
Lactococcus are also used as probiotics. Probiotics 
affect the host beneficially, which may be direct or 
indirect, including enhanced barrier function, 
modulation of the mucosal immune system, 
production of antimicrobial agents, enhancement 
of digestion and absorption of food and alteration 
of the intestinal microflora (Fig. 1) (Jean et al. 
2003).  
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The efficacy of a probiotic effect often depends on 
the mechanism by which they exert their activity. 
By and large, to treat a disease, the probiotics 
follow a set of mechanisms, which is discussed in 
this review. The effective performance of the 
probiotic depends on their strong adherence and 
colonization of the human gut, which in turn 
improves the host immune system (Sarah et al. 
2008). The mechanism of adherence is still under 
investigation, but Lactobacillus plantarum 299v 
has been shown to exhibit a mannose specific 
adhesion by which it can adhere to human colonic 
cells. Once the probiotic adheres to the cell, 
various biological activities take place, which 
primarily include the release of cytokines and 
chemokines. These then exert their secondary 
activity such as stimulation of mucosal and 
systemic host immunity (Delcenserie et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Hypothesised mechanism of immunomodulation by probiotics. (1). Interaction of 
probiotic bacteria with epithelial cells (E) or M cells (M) or the Dendritic cells (DC) 
results in the internalization of the bacteria or its components. (2). This interaction 
stimulates the release of IL-6 by epithelial cells and stimulates macrophages (MQ) and 
dendritic cells to produce TNF-α and IFN-γ. (3). Mast cells (MAC) or also stimulated to 
produce the cytokine IL-4, which together with IL-6 and TGF-β induce the T-
independent switch from IgM to IgA on the surface of B lymphocytes (BL), thereby 
enhancing the production of IgA. (4). IL-6 favours the clonal expansion of IgA B 
lymphocytes. There is also an associated increase in the production of antibodies such as 
IgM, IgG and reduced secretion of IgE. (5). Th1 cells produce pro-inflammatory 
cytokines such as IFNγ, TNFα and IL-2, which stimulate the phagocytosis and 
destruction of microbial pathogens and induce macrophages, natural killer cells and 
cytotoxic T-lymphocytes to kill viruses and tumors (Galdeano et al. 2007). 
 
 
 
Prevention of infectious diseases 
Probiotic strains inhibit the pathogenic organisms 
by competing for the limited substrates required 
for fermentation or the receptors. They prevent the 
adherence of the pathogenic bacteria to the host 
cells by strengthening the barrier effect of the 
intestinal mucosa (Eizaguirre et al. 2002; Mangell 
et al. 2002) and release of gut-protective 
metabolites (arginine, glutamine, short-chain fatty 
acids and conjugated linoleic acids). Probiotic acts 
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as antimicrobial by secreting the products called 
bacteriocins and substances such as organic acids 
(lactic, acetic and butyric acid) and H2O2 (De 
Keersmaecker et al. 2006). For example, 
Lactobacillus acidophilus has been shown to 
produce two compounds, bacteriocin lactacin B 
and acidolin. Lactacin B was shown to inhibit 
Lactobacilli in-vitro, whereas acidolin inhibited 
enteropathogenic organisms. Silva et al. (1987) 
demonstrated an inhibitory substance produced by 
Lactobacillus GG with similar broad spectrum 
activity. They also lower the intestinal pH (De 
Keersmeacker et al. 2006), agglutinates pathogenic 
microorganisms, binds and metabolise toxic 
metabolites (Fonden et al. 2000; Oatley et al. 
2000; Haskard et al. 2001) or regulate the 
intestinal motility (Marteau et al. 2002) and mucus 
production (Mattar et al. 2002; Vrese and Marteau 
2007).  
The clinical data show that the intake of  
 
Lactobacillus reuteri significantly reduces the 
incidence or severity of diarrhoea of different 
origins and reduces the gastrointestinal illness or 
infections. The ability of L. reuteri to influence the 
basic immune responses in the human 
gastrointestinal tract may be the basis for an 
improved protection against the pathogenic 
infection (Connolly 2004). Many different strains 
are known to treat diarrhea caused by (primary) 
lactose intolerance; acute diarrhea from viral and 
bacterial infections, e.g. nosocomial rotavirus 
infections in children, gastrointestinal infections in 
children in day-care centers and travelers’ 
diarrhea; antibiotic-associated diarrhea (AAD); 
Clostridium difficile gastroenteritis; diarrhea in 
tube-fed patients; chemo- or radiotherapy induced 
diarrhea; inflammatory bowel diseases (Crohn’s 
disease, ulcerative colitis and pouchitis); small 
bowel bacterial overgrowth; and irritable bowel 
syndrome (IBS) with diarrhea (Fig 2) (Michael de 
Vrese and Marteau 2007). 
 
 
 
Figure 2 - List of various diseases that are possibly treated by probiotics. 
 
 
The daily intake of L. reuteri in humans 
significantly reduced the number of reported sick 
days due to common infections, and this effect was 
even more pronounced in the shift workers 
(Tubelius et al. 2005). The daily consumption of L. 
reuteri at the dosage of 1010 CFU for 21 days was 
shown to be safe and had no side effects on the 
adults infected with HIV (Wolf 1998). A short 
term daily ingestion of L. reuteri delivered by 
drinking straw or tablets reduced the levels of 
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salivary Streptococci in young adults (Caglar et al. 
2006). The L. reuteri supplementation during and 
after Helicobacter pylori eradication therapy 
significantly reduced the frequency and intensity 
of antibiotic associated side effects (Lionetti et al. 
2006). The administration of L. reuteri 
significantly decreased UBT (Urea Breath Test) 
values in H. pylori positive subjects, 
demonstrating that L. reuteri suppressed H. pylori 
density (Imase et al. 2005). The probiotic 
supplementation with L. reuteri has a beneficial 
effect on H. pylori infection in humans (Saggioro 
et al. 2005).  
 
Stimulation of mucosal and systemic host 
immunity 
There is considerable evidence from the animal 
studies that probiotic organisms can modulate the 
mucosal and systemic immune systems. Link-
Amster et al. (1994) fed 16 volunteers with 
fermented milk supplemented with L. acidophilus, 
Bifidobacterium bifidum Bb12 and Streptococcus 
thermophilus for three weeks during when they 
injected attenuated Salmonella typhi Ty21a 
vaccine. Results showed that the specific serum 
IgA titre rise was significantly higher in the 
controls, denoting an improvement in the humoral 
immune response.  
Stimulation of the immune system in response to 
rotavirus infection was studied by Kaila et al. 
(1992a). The 39 children with acute rotavirus 
diarrhoea were randomly assigned to receive 
Lactobacillus casei GG or a placebo milk product. 
They found an increased IgA specific antibody 
secreting cell response to rotavirus in the probiotic 
group, associated with a reduction in diarrhoea. 
When they repeated this study with heat 
inactivated Lactobacillus casei GG, specific IgA 
levels were unaltered but the duration of diarrhoea 
was reduced. Finally, they concluded that 
probiotics must have interacted beneficially with 
the mucosal immune system. The microorganisms 
present in the gastrointestinal tract (including the 
endogenous flora), interact with the epithelial and 
immune cells. The cytokine response is initially 
manifested by the release of interleukin 8 (IL-8), 
which leads to migration of neutrophils and 
monocytes to the mucosa (Salminen et al. 1998). 
Activated monocytes and dendritic cells in the 
lamina propria produce tumor necrosis factor α 
(TNF-α) as well as IL-1 and IL-6 (Venkat et al. 
2004). The IL-1 and IL-6 stimulate CD41 T cells 
(type 1), and these produce a variety of cytokines 
including IL-4, -5, IL-6, and interferon-γ. This 
response is unable to clear the infection and 
sustains inflammation. Different species of 
lactobacilli exert different activation patterns on 
the dendritic cells (Raja 2003). Further, L. reuteri 
DSM12246 inhibited the activities of other 
species. Clearly, not all the probiotics share the 
same immunomodulating properties and can even 
have opposite effects on some parameters.  
 
Probiotics on non-gastrointestinal problems 
Apart from the gastrointestinal diseases, probiotics 
possess functions such as antiallergic activity. 
Probiotics are used in the treatment of allergic 
conditions, including rhinitis, atopic dermatitis and 
food allergy (Norin et al. 2004). Although initial 
results in the studies of children have been 
promising, a definitive role for any of these 
indications remains unproven. Intestinal 
microflora can contribute to the processing of food 
antigens in the gut, resulting in food 
hypersensitivity, of which atopic disease is a 
manifestation. Probiotics have the potential to 
modify the structure of potential antigens, reduce 
their immunogenicity, reduce intestinal 
permeability and generation of proinflammatory 
cytokines that are elevated in the patients with a 
variety of allergic disorders. They directly 
modulate the immune system through the 
induction of anti-inflammatory cytokines or 
through increased production of secretory, which 
contribute to an exclusion of antigens from the 
intestinal mucosa (Kaila et al. 1992b). Probiotics 
could have a potential effect on bone accretion by 
microbial production of metabolites or enzymes or 
synthesis of vitamins (Norin et al. 2004; Katharina 
et al. 2007) because several vitamins are also 
involved in calcium metabolism and are required 
for bone matrix formation and bone accretion, e.g. 
vitamin D, C, or K or folate (Weber 1999). 
Mechanisms that may contribute to the bone 
health-supporting effect include degradation of 
mineral complexing phytic acid, stimulation of 
calcium uptake by enterocytes and probiotic 
antiarthritic effect (Katharina et al. 2007). 
 
Probiotics as a feed for animals and 
aquaculture 
The usage of probiotics is not limited to the 
humans. They have many beneficial effects when 
they are used in animal feeds and aquaculture. 
These effects include exclusion of pathogens, 
improved digestion and absorption of nutrients. 
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The effect of feeding Lactobacillus on the gut 
microflora, growth and survival of post-larvae of 
Macrobrachium rosenbergii (de Man) has been 
studied by Venkat et al. (2004). The commercial 
products can be administered through water or 
incorporated in the feed. A wide range of 
microalgae such as Dunaliella salina (Raja et al. 
2007a,b), Spirulina platensis (Raja et al. 2008), 
Chlorella vulgaris (Raja et al. 2008) and yeasts 
such as Debaryomyces, Phaffia and 
Saccharomyces Gram-positive bacteria such as 
Bacillus, Carnobacterium, Enterococcus, 
Lactobacillus, Lactococcus, Micrococcus, 
Streptococcus and Weissella (Reid 2002) and 
Gram-negative bacteria such as Aeromonas, 
Alteromonas, Photorhodobacterium, 
Pseudomonas and Vibrio have been evaluated. 
Probiotics actively inhibit the colonization of 
potential pathogens in the digestive tract by 
antibiosis or by competing for the nutrients and 
space, alteration of microbial metabolism or by the 
stimulation of host immunity. Probiotics may 
stimulate appetite and improve the nutrition by the 
production of vitamins, detoxification of 
compounds in the diet, and by the breakdown of 
indigestible compounds into simpler compounds. 
There is evidence that probiotics are effective at 
inhibiting a wide range of fish pathogens, but the 
reason for the inhibitions is often unstated (Irianto 
and Austin 2002). In addition, probiotics have 
been particularly useful in the early stages of chick 
growth since the gut of the newly hatched chick is 
sterile and administering probiotics through water 
at this stage helps to build up the beneficial 
bacteria in its gut much faster than the normal 
course (Singh et al. 2008). 
The balance between the phytoplankton, 
zooplankton and beneficial bacteria during the 
culture process play a crucial role in the 
maintenance of pond health (Irianto and Austin 
2002). Probiotics have also been used in a big way 
as pond cleaners in aquaculture (Balcazar et al. 
2006). Probiotic bacteria directly uptake or 
decompose the organic matter or toxic material 
and improve the quality of water. The microbial 
cultures produce a variety of enzymes such as 
amylase, protease, lipase, xylanase and cellulase in 
high concentrations than the native bacteria, which 
help in degrading the waste. These bacteria have a 
wide range of tolerance for salinity, temperature 
and pH, which are the normal ambience of 
 
aquaculture operations. The use of antibiotics in 
aquaculture is banned due to the possible side 
effects of antibiotics on the marine food (Balcazar 
et al. 2006). Hence, the usage of probiotics is 
recommended to counter the effect of viral and 
bacterial infections in commercial aquaculture. 
The pond probiotics also have a special blend of 
denitrifying bacteria that remove the algae’s 
primary source of food namely nitrogen from the 
pond water. This drastic reduction in nitrogen 
concentration makes it difficult for the algae to 
bloom (Hallegraeff 1993).  
 
 
CONCLUSION 
 
The use of probiotics in the day-to-day medicine 
in the treatment of gastrointestinal disorders is 
increasing with the discovery of the beneficial 
effects of these agents. It is important to assess the 
degree of effects on the population and activity of 
gut microbes. There are several reports on the role 
of probiotics in reducing the colon cancer but the 
reoccurrence of cancer due to such treatments has 
not yet been established. Studies documenting the 
probiotic effects in humans are limited, although 
results in several biological systems are intriguing. 
The degree of evidence required to substantiate the 
bioactivity of food ingredients is not clearly 
established. This is a complex issue involving both 
regulatory and scientific considerations. The 
commercial use of probiotics, however, has 
proceeded because essentially no risk is associated 
with the consumption of well-defined probiotics in 
foods and many benefits are possible. Perhaps the 
most compelling evidence for probiotic efficacy is 
in the areas of anti-diarrheal effects and improved 
digestion of lactose in lactose-intolerant people, 
because these findings have been substantiated in 
human studies.   
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